What did it prove and why is it significant for patients in India?The SOUL (semaglutide cardiovascular outcomes) trial showed that oral semaglutides significantly reduced heart attacks, strokes and cardiovascular death in people with type 2 diabetes who were already at high cardiovascular risk
Compounded semaglutide is prepared by licensed 503A compounding pharmacies, which operate under USP standards and state pharmacy board regulations, not FDA approval
Note: Ozempic , Mounjaro , and metformin are not FDA-approved to treat obesity or for weight loss
Wegovy (semaglutide), a GLP-1 receptor agonist, is not known to commonly cause flu-like illness
Which is best for heart failure protection
Since many GLP-1 users have other chronic conditions such as diabetes, high blood pressure, and heart disease, users will also receive BPM Connect Pro to track changes in blood pressure